| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT03983824 Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT03983824 Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-05-14 | NCT05711615 Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an… |
date change Primary completion pushed: 2026-05-03 -> 2026-11-03 |
| 2026-05-14 | NCT05711615 Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an… |
date change Completion pushed: 2026-05-03 -> 2026-11-03 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… | Pediatric Cancer | Recruiting |
| NCT04071236 | Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation… | Metastatic Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT04172532 | Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual… | Locally Advanced Pancreatic Adenocarcinoma | Recruiting |
| NCT04068194 | Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation… | Locally Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| Phase 1 | |||
| NCT05711615 | Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an… | Metastatic Dedifferentiated Liposarcoma | Recruiting |
| NCT04555577 | Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients… | Glioblastoma | Recruiting |
| NCT05687136 | Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT04533750 | Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With… | Advanced Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT04092270 | A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With… | Endometrial High Grade Endometrioid Adenocarcinoma | Active, Not Recruiting |
| NCT04750954 | Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual… | Neuroendocrine Neoplasm | Active, Not Recruiting |
| NCT03983824 | Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone… | Recurrent Acute Myeloid Leukemia | Active, Not Recruiting |